Robotic Assisted Surgery In Total Knee Replacement
Robotic Assisted Surgery In Total Knee Replacement Versus Manual Total Knee Arthroplasty: A Randomized Controlled Trial
The goal of this clinical trial is to compare robotic arm assisted surgery with manual surgery in patients operated with knee replacement.
The main aim of the study is to compare changes in joint awareness (measured by the Forgotten Joint Score.
Participants who are listed for knee arthroplasty are randomised to either robotic arm assisted surgery or manual surgery.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Title:
Robotic Assisted Surgery in total knee replacement versus Manual Total Knee Arthroplasty: A randomised controlled trial
Type of study:
CE marked device study
Trial Design:
Multi-center site prospective parallel group randomised controlled trial
Trial Participants:
Listed for routine primary total knee replacements
Investigational Device:
MAKO Robotic Arm Assisted Surgical System
Control:
Conventional jig-based surgery
Implant (Intervention and Control):
Triathlon TKR
Planned Sample Size:
200 (100 MAKO, 100 Manual)
Follow-up duration:
24 months following surgery
Planned Trial Period:
Nov 2022 - 2024
Primary Objective:
To compare changes in joint awareness (measured by the Forgotten Joint Score (FJS)20) from baseline to 12 months following TKR between the two groups.
Secondary Objectives
- To compare pain measured using the pain visual analogue scale.
- To compare the health-related quality of life using the EQ5D-3L at baseline, 3, 12 and 24 months.
- To compare changes in knee function in activities of daily living (measured by the Oxford knee score (OKS)19) from baseline to 3, 12 and 24 months.
- To compare changes in clinically assessed pain and stiffness (measured by the Knee Society Score (KSS)) at baseline to 3 and 12 months.
- To compare revision rate using implant migration measured by CTMA at 12 and 24 months as a surrogate marker for revision.
Primary Endpoint:
Functional outcome measured by the changes in joint awareness of the FJS score at 12 months following the intervention.
Secondary Endpoints:
Secondary outcomes will be collected up to 24 months following the intervention.
Device Name:
Both arms will receive Triathlon TKR with a highly crossed linked (X3) cruciate retaining polyethylene insert.
The intervention group will utilise the MAKO robotic arm to make the bone cuts.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gothenburg, Sweden
- Recruiting
- Sahlgrenska University Hospital
-
Contact:
- Maziar Mohaddes, Associate Professor, MD
- Phone Number: 0046313421000
- Email: mazmo1@vgregion.se
-
Principal Investigator:
- Mazaíar Mohaddes, Assoc Professor, MD
-
Örebro, Sweden, 705 85
- Recruiting
- Örebro University Hospital, Department of Medical Sciences
-
Contact:
- Per Wretenberg, Professor
- Phone Number: 0046706636686
- Email: per.wretenberg@regionorebrolan.se
-
Contact:
- Gunnar Falk, MD
- Phone Number: 004670-5698284
- Email: gunnar.falk@regionorebrolan.se
-
Principal Investigator:
- Per Wretenberg, Professor
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Listed for elective primary TKR for end stage osteoarthritis
- Suitable candidate for a cruciate retaining TKR (Triathlon prosthesis)
- Male or Female, aged 18 years or above (18-80 at the time of listing for surgery).
- Able to understand and provide written consent.
Exclusion Criteria:
- Varus deformity of > 20 degrees observed by consultant on examination
- Patient is unable to comply with the study protocol (incl. refusal for CT scan)
- Female participant who is pregnant, lactating or planning pregnancy during the course of the study.
- Requires patella resurfacing
- Inability to understand the patient information for the study, provide written informed consent or answer study questionnaires for cognitive or language reasons
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Conventional
|
Total knee arthroplasty
|
|
Experimental: MAKO TKA
|
Total knee arthroplasty
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Forgotten Joint Score
Time Frame: 1 year
|
Patient-reported outcome
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee pain
Time Frame: 2 years
|
Patient-reported outcome
|
2 years
|
|
EQ-5D
Time Frame: 3, 12, 24 months
|
Patient-reported outcome
|
3, 12, 24 months
|
|
Oxford Knee Score
Time Frame: 3, 12, 24 months
|
Patient-reported outcome
|
3, 12, 24 months
|
|
Knee Society Score
Time Frame: 3, 12, 24 months
|
Physician-reported outcome
|
3, 12, 24 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RAKER
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.